Press release
Dermatophytic Onychomycosis Market to Reflect a Significant CAGR of 8.3% by 2025
The global dermatophytic onychomycosis therapeutics market is anticipated to expand at a healthy CAGR during the forecast period. By product type, the market is segmented into Nail paint and tablet, which is again sub-divided into prescription (Rx) and over-the-counter (OTC) sub segments. The nail paint segment is expected to contribute a maximum share to the global dermatophytic onychomycosis therapeutics market and expand at the fastest CAGR of 8.3% during the forecast period. By treatment, the market is segmented into topical and oral therapy.
Dermatophytic Onychomycosis Market Research Report Overview @ https://www.persistencemarketresearch.com/market-research/dermatophytic-onychomycosis-therapeutics-market.asp
Among these, the topical segment is anticipated to be dominant throughout the forecast period and projected to account for about 70% share of the total global dermatophytic onychomycosis market revenue by 2021. By distribution channels, the market is segmented into hospitals, dermatology and podiatry clinics, independent pharmacies, mail order pharmacies, and drug stores. Among these, drug stores are estimated to be largest segment with 47% share of the total global market revenue by 2015 end. The drug stores segment is expected to register the fastest CAGR during the forecast period. Independent pharmacies are projected to be the second most attractive segment of the global dermatophytic onychomycosis therapeutics market by 2015 end.
Request Sample Report @ https://www.persistencemarketresearch.com/samples/5840
Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs. However, adverse effects associated with anti-fungal drugs and lack of awareness about dermatophytic onychomycosis in Asia Pacific, Middle East and Africa, and Latin America are expected to impede growth of the global dermatophytic onychomycosis therapeutics market.
This report covers global and regional trends along with an analysis of the market potential. North America is expected to account for over 43% revenue share of the total dermatophytic onychomycosis therapeutics market by 2015 end i.e. holding the maximum market share. Whereas Europe is projected to grow at a healthy CAGR of 7.3% due to increasing awareness about fungal nail infections.
Download and View Report TOC, Figures and Tables @ https://www.persistencemarketresearch.com/market-research/dermatophytic-onychomycosis-therapeutics-market/toc
Global dermatophytic onychomycosis therapeutics market report begins with an overview of the global market in terms of value. This section includes detailed analysis of key trends, drivers and restraints, and opportunities. All of these are factors that impact market growth. Impact analysis of key growth drivers and restraints based on the weighted average of each one of these factors in a model-based approach is included in the market report to better equip clients with crystal clear decision-making insights.
Key players of the global dermatophytic onychomycosis therapeutics market include Galderma S.A., Valeant Pharmaceuticals International Inc., Novartis AG, Pfizer Inc., Janssen Pharmaceuticals, and others. Leading companies in this market collaborate with healthcare solutions and services providers in order to advance operational efficiencies and provide improved patient care.
Get Full Report now @ https://www.persistencemarketresearch.com/checkout/5840
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Dermatophytic Onychomycosis Market to Reflect a Significant CAGR of 8.3% by 2025 here
News-ID: 920632 • Views: …
More Releases from Persistence Market Research
Blood Collection Tubes Market Size, Growth, Share & Trends 2025-2032 | Global In …
The blood collection tubes market plays a pivotal role in modern healthcare by enabling safe, efficient, and accurate collection, storage, and transportation of blood samples. Extensively used in diagnostic laboratories, hospitals, and research centers, these tubes are critical for hematology, biochemistry, immunology, and molecular testing. They help maintain sample integrity, minimize contamination risks, and streamline laboratory workflows, making them indispensable in clinical diagnostics.
Request a Sample:
https://www.persistencemarketresearch.com/samples/35126
Market Overview
According to a recent study…
Frozen Pastries Market to Reach $3.8 Bn by 2032 Driven by Convenience and Ready- …
The global frozen pastries market is set for consistent expansion over the next decade, driven by the growing demand for convenient, ready-to-bake bakery products and evolving consumer lifestyles. According to market projections, the global frozen pastries market size is likely to be valued at US$ 2.6 billion in 2025 and is estimated to reach US$ 3.8 billion by 2032, growing at a CAGR of 5.7% during the forecast period from…
Cookies Market to Reach US$ 54.4 Bn by 2032 Driven by Rising Demand for Premium …
The global cookies market is witnessing steady growth, with its valuation expected to reach US$ 38.3 billion in 2025. According to projections, the market is set to rise significantly and reach approximately US$ 54.4 billion by 2032, expanding at a compound annual growth rate (CAGR) of 5.1% between 2025 and 2032. This growth trajectory is fueled by evolving consumer lifestyles, increasing demand for convenient and on-the-go snacks, and the rising…
Flaxseeds Market Growth Driven by Health Trends | Valued at US$ 1,284.7 Mn in 20 …
The global flaxseeds market is witnessing substantial expansion, driven by the growing consumer awareness of health benefits associated with flaxseed consumption and its increasing use across diverse industries such as food and beverages, pharmaceuticals, and cosmetics. According to recent industry analysis, the global flaxseeds market size is likely to be valued at US$ 1,284.7 million in 2025, and is projected to reach US$ 2,145.3 million by 2032, expanding at a…
More Releases for Dermatophytic
Call for Automation to Drive the Dermatophytic Onychomycosis Therapeutics Market
Advancements in medicine, diagnosis of varieties of illnesses, and increasing elder population at an unprecedented rate have resulted in high demand for novel drugs and therapies for dermatophytic onychomycosis treatment. In 2021, the dermatophytic onychomycosis therapeutics market was valued at nearly US$ 5.5 Bn, and is set to experience a 6.5% CAGR over the forecast period (2022-2031).
Presence and availability of a large clinical pipeline with reference to therapeutic approaches based…
Dermatophytic Onychomycosis Therapeutics (DOT) Market 2022 | Detailed Report
The research reports on “Dermatophytic Onychomycosis Therapeutics (DOT) Market” report gives detailed overview of factors that affect global business scope. Dermatophytic Onychomycosis Therapeutics (DOT) Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample…
Dermatophytic Onychomycosis Therapeutics (DOT) Market
Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs. However, adverse effects associated with anti-fungal drugs and lack of awareness about dermatophytic onychomycosis in Asia Pacific, Middle East and Africa, and Latin…
Dermatophytic Onychomycosis Market Expected to Witness a Sustainable Growth
According to a new report published by Allied Market Research, titled, " Dermatophytic Onychomycosis Market by Product (Nail Paint and Tablet), Route of Administration (Topical and Oral Therapy), and End User (Hospitals, Dermatology & Podiatry Clinics, Independent Pharmacies, Mail Order Pharmacies, and Drug Stores) - Global Opportunity Analysis and Industry Forecast, 2020-2027".
The global market size of Dermatophytic Onychomycosis market is $XX million in 2019 with XX CAGR, and it is…
Dermatophytic Onychomycosis Market Poised to Rake US$ 4,706.3 Mn by 2021
Key players of the global dermatophytic onychomycosis therapeutics market include Galderma S.A., Valeant Pharmaceuticals International Inc., Novartis AG, Pfizer Inc., Janssen Pharmaceuticals, and others. Leading companies in this market collaborate with healthcare solutions and services providers in order to advance operational efficiencies and provide improved patient care.
Persistence Market Research (PMR) delivers key insights on the global dermatophytic onychomycosis therapeutics Market in its latest report titled “Global Market Study on Dermatophytic…
Dermatophytic Onychomycosis Market : Topical segment to account 70% share
The global dermatophytic onychomycosis therapeutics market is anticipated to expand at a healthy CAGR during the forecast period. By product type, the market is segmented into Nail paint and tablet, which is again sub-divided into prescription (Rx) and over-the-counter (OTC) sub segments. The nail paint segment is expected to contribute a maximum share to the global dermatophytic onychomycosis therapeutics market and expand at the fastest CAGR of 8.3% during the…
